Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status

Published:2007-09-13 Issue:3 Volume:22 Page:646-649
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Cortelezzi A,Gritti G,Del Papa N,Pasquini M C,Calori R,Gianelli U,Cortiana M,Parati G,Onida F,Sozzi F,Vener C,Bianchi P,Deliliers G L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404943.pdf

Reference9 articles.

1. Farber HW, Loscalzo J . Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655–1665.

2. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245.

3. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A . Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001; 120: 801–808.

4. Garcia-Manero G, Schuster SJ, Patrick H, Martinez J . Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol 1999; 60: 130–135.

5. Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of pulmonary hypertension in patients with myeloproliferative neoplasms: single-center study;The Egyptian Journal of Haematology;2024-01

2. Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety;Journal of Hematology & Oncology;2023-07-27

3. Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease;International Journal of Hematology;2022-10-02

4. Pulmonale Hypertonie und Polycythaemia vera;Pneumologie;2022-04-05

5. Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension;Aging;2021-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3